title: Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
abstract: Immunodeficient hosts engrafted with human lymphohaematopoietic cells hold great promise as a preclinical bridge for understanding human haematopoiesis and immunity. We now describe a new immunodeficient radioresistant non-obese diabetic mice (NOD) stock based on targeted mutations in the recombination activating gene-1 (Rag1(null)) and interleukin (IL)-2 receptor common gamma chain (IL2rgamma(null)), and compare its ability to support lymphohaematopoietic cell engraftment with that achieved in radiosensitive NOD.CB17-Prkdc(scid) (NOD-Prkdc(scid)) IL2rgamma(null) mice. We observed that immunodeficient NOD-Rag1(null) IL2rgamma(null) mice tolerated much higher levels of irradiation conditioning than did NOD-Prkdc(scid) IL2rgamma(null) mice. High levels of human cord blood stem cell engraftment were observed in both stocks of irradiation-conditioned adult mice, leading to multi-lineage haematopoietic cell populations and a complete repertoire of human immune cells, including human T cells. Human peripheral blood mononuclear cells also engrafted at high levels in unconditioned adult mice of each stock. These data document that Rag1(null) and scid stocks of immunodeficient NOD mice harbouring the IL2rgamma(null) mutation support similar levels of human lymphohaematopoietic cell engraftment. NOD-Rag1(null) IL2rgamma(null) mice will be an important new model for human lymphohaematopoietic cell engraftment studies that require radioresistant hosts.
authors.affiliation: Diabetes Division, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Pearson
authors.forename: L D
authors.initials: LD
authors.lastname: Shultz
authors.forename: D
authors.initials: D
authors.lastname: Miller
authors.forename: M
authors.initials: M
authors.lastname: King
authors.forename: J
authors.initials: J
authors.lastname: Laning
authors.forename: W
authors.initials: W
authors.lastname: Fodor
authors.forename: A
authors.initials: A
authors.lastname: Cuthbert
authors.forename: L
authors.initials: L
authors.lastname: Burzenski
authors.forename: B
authors.initials: B
authors.lastname: Gott
authors.forename: B
authors.initials: B
authors.lastname: Lyons
authors.forename: O
authors.initials: O
authors.lastname: Foreman
authors.forename: A A
authors.initials: AA
authors.lastname: Rossini
authors.forename: D L
authors.initials: DL
authors.lastname: Greiner
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000276:immunology; D036101:Cord Blood Stem Cell Transplantation; D004195:Disease Models, Animal; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D016130:Immunophenotyping; D053631:Interleukin Receptor Common gamma Subunit / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D036102:Peripheral Blood Stem Cell Transplantation; D011836:Radiation Tolerance / Q000235:genetics / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014183:Transplantation, Heterologous
chemical_list: D053631:Interleukin Receptor Common gamma Subunit
references.citation: Ann N Y Acad Sci. 2007 Apr;1103:77-89
references.pmid: 17332083
references.citation: Ann N Y Acad Sci. 2007 Apr;1103:90-3
references.pmid: 17376822
references.citation: Clin Exp Immunol. 2008 Jun;152(3):406-14
references.pmid: 18435804
references.citation: J Exp Med. 1998 Sep 21;188(6):1117-24
references.pmid: 9743530
references.citation: Science. 2004 Apr 2;304(5667):104-7
references.pmid: 15064419
references.citation: Blood. 2002 Nov 1;100(9):3175-82
references.pmid: 12384415
references.citation: J Exp Med. 1997 Oct 20;186(8):1223-32
references.pmid: 9334361
references.citation: J Exp Med. 1997 Oct 20;186(8):1269-75
references.pmid: 9334366
references.citation: Immunity. 1999 Aug;11(2):163-71
references.pmid: 10485651
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8092-7
references.pmid: 10393953
references.citation: J Immunol. 1997 Apr 15;158(8):3578-86
references.pmid: 9103418
references.citation: Clin Exp Immunol. 1992 May;88(2):243-52
references.pmid: 1349272
references.citation: Blood. 2003 Oct 1;102(7):2522-31
references.pmid: 12791667
references.citation: Blood. 2003 Jun 15;101(12):5007-9
references.pmid: 12576313
references.citation: Transplantation. 2003 Oct 15;76(7):1036-42
references.pmid: 14557749
references.citation: Nature. 1983 Feb 10;301(5900):527-30
references.pmid: 6823332
references.citation: Scand J Immunol. 1994 Nov;40(5):529-34
references.pmid: 7973459
references.citation: Nat Rev Immunol. 2007 Feb;7(2):118-30
references.pmid: 17259968
references.citation: J Infect Dis. 1995 Oct;172(4):974-82
references.pmid: 7561218
references.citation: J Immunol. 2005 May 15;174(10):6477-89
references.pmid: 15879151
references.citation: Clin Immunol. 2008 Mar;126(3):303-14
references.pmid: 18096436
references.citation: Blood. 2005 Sep 1;106(5):1565-73
references.pmid: 15920010
references.citation: J Immunol. 2006 Feb 15;176(4):2053-8
references.pmid: 16455958
references.citation: J Immunol. 2000 Mar 1;164(5):2496-507
references.pmid: 10679087
references.citation: J Immunol. 1995 Jan 1;154(1):180-91
references.pmid: 7995938
references.citation: Annu Rev Immunol. 1991;9:323-50
references.pmid: 1910681
references.citation: Nature. 1988 Sep 15;335(6187):256-9
references.pmid: 2970594
references.citation: J Exp Med. 1995 Jun 1;181(6):2265-70
references.pmid: 7760012